Dr. Reddy's Laboratories Limited updates on USFDA GMP inspection at Bollaram unit

Dr. Reddy's Laboratories Limited has announced that the United States Food & Drug Administration (USFDA) today completed a routine GMP inspection at our API manufacturing facility (CTO 1) in Bollaram, Hyderabad. The inspection was conducted from 1st May, 2023 to 5th May, 2023. We have been issued a Form 483 with one observation, which we will address within the stipulated timeline.

Shares of Dr. Reddy's Laboratories Limited was last trading in BSE at Rs. 4936.90 as compared to the previous close of Rs. 4969.60. The total number of shares traded during the day was 4733 in over 979 trades.

The stock hit an intraday high of Rs. 4987.00 and intraday low of 4920.10. The net turnover during the day was Rs. 23442811.00.

Source : Equity Bulls

Keywords

DrReddysLaboratories INE089A01023 USFDA GMPInspection APIManufacturingFacility